This subline is highly invasive in response to upregulation of autocrine EGFR signalling (Xie et al, 1995; Turner et al, 1996) that exists in practically all prostate carcinomas (Kim et al, 1999). The gene discussed is EGFR; the disease is prostate carcinoma.